|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
8.370 -0.080 (-0.947%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 818,973 | 947,679 | 725,537 | 867,058 |
| Net Cash from / (used in) Investing Activities | -- | (231,772) | (368,804) | (298,305) | (25,703) |
| Net Cash from / (used in) Financing Activities | -- | (280,100) | (342,205) | (166,659) | (279,804) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 307,101 | 236,670 | 260,573 | 561,551 |
| Cash & Cash Equivalents at beginning of period | -- | 2,450,173 | 2,196,323 | 1,940,273 | 1,383,232 |
| Effect of Foreign Exchange Rate Changes | -- | (9,012) | 17,180 | (4,523) | (4,510) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 2,748,262 | 2,450,173 | 2,196,323 | 1,940,273 |
| Remarks: | Real time quote last updated: 22/11/2024 14:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 399,765 |
| %Change | 14.910% |
| EPS / (LPS) | RMB 0.499 |
| NBV Per Share (¥) | RMB 4.383 |